Use of Myrbetriq
(mirabegron) is a
prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.
Important Safety Information
Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.
Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.
Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as
thioridazine (Mellaril™ and Mellaril-S™),
solifenacin succinate (VESIcare®).
Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.
Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).
For further information, please talk to your healthcare professional and see accompanying
Patient Product Information
for Myrbetriq® (mirabegron).
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Myrbetriq® is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.